You can purchase Mounjaro® weight loss injections through our US-registered online prescribing service at Lovely Meds. Mounjaro® is the latest GLP-1 weight loss injection available in the US, providing effective support for individuals aiming for significant weight loss.

After completing an online assessment with our licensed medical team, your order will be reviewed. If a prescription is approved, it will be sent to our pharmacy team, who will prepare and ship your treatment directly to your door.

• How It Works: Suppresses appetite and reduces fat storage
• Effectiveness: 15-20% weight loss on average
• Side Effects: Common side effects include fatigue, dizziness, insomnia
• Dosage: Starting at 2.5mg once weekly, titrating up to a maximum of 15mg

Mounjaro® works by mimicking the natural hormone GLP-1 in your gut, which regulates hunger after a meal. By acting similarly to GLP-1, Mounjaro® helps you feel fuller for longer, leading to reduced calorie intake and effective weight loss. Focusing on a reduced-calorie diet while using Mounjaro can amplify its benefits.

Additionally, Mounjaro® helps prevent excess sugar from being converted into fat, thereby reducing fat storage in the body.

Mounjaro® should be used for weight loss if you have already tried and failed to lose weight through exercise and diet alone.

Mounjaro is suitable for patients with a BMI over 30 or a BMI over 27 with additional risk factors such as:

• Type 2 diabetes
• High cholesterol
• Obstructive sleep apnea
• High blood pressure

Mounjaro® is currently the most effective GLP-1 weight loss medication available, with patients losing an average of 15-20% of their initial body weight after completing treatment. The highest strength of Mounjaro®, 15mg, has shown the best results.

• Patients maintaining at 10mg have reported an average weight loss of 19%.
• Patients maintaining at 15mg can lose around 15%.

The lower strengths of Mounjaro® (2.5mg and 5mg) are primarily used for dose titration and to help your body adjust to the treatment, so they are not expected to deliver maximum weight loss results.

Mounjaro® is titrated gradually to minimize side effects and maximize effectiveness. Below is the recommended titration schedule:

Mounjaro® Dosing Schedule:

• Weeks 1-4: 2.5 mg (Initial dose for titration)
• Weeks 5-8: 5 mg (Assess tolerance before increasing the dose)
• Weeks 9-12: 7.5 mg (Assess tolerance before increasing the dose)
• Weeks 13-16: 10 mg (Monitor for efficacy and tolerability)
• Weeks 17-20: 12.5 mg (Further increase based on clinical response)
• Weeks 21 and onwards: 15 mg (Maintenance dose if well tolerated)

If side effects persist for more than two weeks, discuss this with your doctor or pharmacist.

The most common side effects of Mounjaro® affect the digestive system, including nausea, vomiting, diarrhea, and constipation. These effects usually subside after a few days as your body adjusts to the treatment.

Other common side effects include:

• Feeling weak or tired
• Dizziness
• Insomnia
• Injection site reactions such as bruising, pain, or rash

The gradual titration schedule of Mounjaro® helps minimize these side effects. If you experience persistent or severe side effects, consult your doctor or pharmacist.

Yes, we deliver to states including Texas, Florida, California, New York, and Illinois. Our service ensures access to high-quality medications and telehealth support, with discreet shipping and prompt delivery straight to your doorstep.

We currently do not prescribe in the following states. Orders from these states will be rejected: KS – Kansas, KY – Kentucky, LA – Louisiana, MS – Mississippi, NM – New Mexico, SC – South Carolina, AR – Arkansas.

Please be advised: GLP-1 medications may cause serious side effects, including an increased risk of thyroid C-cell tumors. Do not use these medications if you or your family have a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). Always consult with your healthcare provider before starting any new medication and review all associated warnings and precautions.